Yamada T, Goto Y, Tanaka H, Kimura H, et al. A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study. Eur J Cancer 2023;195:113373.
PMID: 37890349